Home > PE Ratio > GENPHARMASEC

GENPHARMASEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENPHARMASEC is 75.99.

Share Price ₹2.1Jul 04,2025
Market Cap ₹114.1 Cr
Earnings-TTM₹1.5 CrTTM-Consolidated Results
Price/Earnings75.99xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENPHARMASEC is calculated as :

Current Market Cap [ ₹114.1 Cr] as on Jul 04,2025

(/) Earnings [ ₹1.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 75.99x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENPHARMASEC , the investors are currently willing to pay 75.99 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.

Historical PE (Price/Earnings) ratio chart of GENPHARMASEC


PE Ratio Performance Analysis for GENPHARMASEC

- GENPHARMASEC 's latest p/e ratio is 75.99x.

- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2024 to Mar2023 averaged 23.00x.

- GENPHARMASEC 's operated at median p/e ratio of 46x from fiscal years ending March 2018 to 2022.

- Looking back at the last 2 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2023 at 46x.

- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?

Peer Comparison (Dyes & Pigments Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENPHARMASEC 1.5075.99114.1
SUDARSHAN CHEMICAL INDUSTRIES LTD117.8983.539,846.8
KIRI INDUSTRIES LTD-92.56-33.783,126.9
VIDHI SPECIALTY FOOD INGREDIENTS LTD43.4048.322,096.9
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD58.6218.891,107.4
BODAL CHEMICALS LTD18.5053.27985.5
BHAGERIA INDUSTRIES LTD38.6923.68916.3
DYNEMIC PRODUCTS LTD15.0025.32379.9
PODDAR PIGMENTS LTD22.8214.67334.7
ASAHI SONGWON COLORS LTD16.8630.17508.6
JAYSYNTH ORGOCHEM LTD15.6220.46319.6

Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -33.78x
Max industry PE 83.53x
Median industry PE 25.32x
Average industry PE 32.77x



You may also like the below Video Courses